Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Substituted benzene compounds

a technology of substituted benzene and benzene, which is applied in the direction of organic chemistry, organic active ingredients, drug compositions, etc., can solve the problems of complexes lacked the ability to catalyze the methylation of the h3-k27 equivalent residue of a peptidic substrate, disrupted control, and disease states, etc., to inhibit the conversion of h3-k27 and inhibit the activity of histone methyltransfera

Inactive Publication Date: 2016-11-17
EPIZYME
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The invention described in this patent text has technical effects that will be described in detail in the following description and claims.

Problems solved by technology

Disease states result when these controls are disrupted by aberrant expression and / or activity of the enzymes responsible for DNA and histone modification.
It was also demonstrated that all of the mutant forms of EZH2 could be incorporated into the multi-protein PRC2 complex, but that the resulting complexes lacked the ability to catalyze methylation of the H3-K27 equivalent residue of a peptidic substrate.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Substituted benzene compounds
  • Substituted benzene compounds
  • Substituted benzene compounds

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Compound 1: 5-bromo-3-(cyclopentylamino)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methylbenzamide

[1085]

Step 1: Synthesis of methyl 5-bromo-3-(cyclopentyl(methyl)amino)-2-methylbenzoate

[1086]

[1087]To a stirred solution of methyl 5-bromo-3-(cyclopentylamino)-2-methylbenzoate (0.5 g, 1.75 mmol) in acetonitrile (10 mL), Cs2CO3 (1.02 g, 2.63 mmol) and methyl iodide (1.45 g, 3.5 mmol) were added to it. The resulting reaction mixture was stirred at 80° C. for 4 h. Upon completion, the solvent was removed under reduced pressure and residue dissolved in water and extracted with ethyl acetate. Crude material obtained was purified by column chromatography over silica gel affording the desired compound product without further purification (0.39 g).

Step 2: Synthesis of 5-bromo-3-(cyclopentylamino)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methylbenzamide

[1088]

[1089]To a stirred solution of methyl 5-bromo-3-(cyclopentyl(methyl)amino)-2-methylbenzoate (1...

example 2

Synthesis of Compound 2: 5-bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-3-(methyl(piperidine-4-yl)amino)benzamide

[1090]

Step 1: 5-bromo-2-methyl-3-nitrobenzoic acid

[1091]

[1092]To stirred solution of 2-methyl-3-nitrobenzoic acid (50 g, 276.2 mmol) in conc. H2SO4 (200 mL), 1,3-dibromo-5,5-dimethyl-2,4-imidazolidinedione (43.4 g, 151.8 mmol) was added portion wise at room temperature and reaction mass was stirred at room temperature for 5 h. On completion, reaction mass was poured on ice cold water, solid precipitated was filtered, resulting residue was washed with water and dried under vacuum giving the desired compound (71.7 g, 99.9%) which was used for further reaction.

Step 2: methyl 5-bromo-2-methyl-3-nitrobenzene

[1093]

[1094]To a stirred solution of 5-bromo-2-methyl-3-nitrobenzoic acid (287 g, 1103 mmol) in DMF (150 mL), sodium carbonate (468 g, 4415 mmol) and methyl iodide (626.63 g, 4415 mmol) were added. Resulting reaction mass was heated at 60° C. for 8 ...

example 3

Synthesis of Compound 3: 5-chloro-3-(cyclohexyl(methyl)amino)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methylbenzamide

[1106]

Step 1: 5-chloro-2-methyl-3-nitrobenzoic acid

[1107]

[1108]5-Chloro-2-methylbenzoic acid (4 g, 23.39 mmol) was added to cooled conc. H2SO4 (27 mL) at −10° C. lot wise. After 10 minutes nitrating mixture {prepared as mixing Conc. HNO3 (3.3 g, 52.68 mmol) with conc. H2SO4 (4.4 mL)} was added drop wise at −10° C. Resulting reaction mass was stirred at −10° C. for 30 minutes. On completion, reaction mixture was poured on ice cold water, solid precipitated was filtered, washed with water and dried under vacuum giving desired compound (4.95 g, 99%).

Step 2: methyl 5-chloro-2-methyl-3-nitrobenzoate

[1109]

[1110]To stirred solution of 5-chloro-2-methyl-3-nitrobenzoic acid (6.75 g, 31.25 mmol) in DMF (33 mL), sodium carbonate (13.23 g, 125.18 mmol) and methyl iodide (17.77 g, 125.2 mmol) were added. Resulting reaction mass was heated at 60° C. for 4 h. On com...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pharmaceutical compositionsaaaaaaaaaa
Login to View More

Abstract

The present invention relates to substituted benzene compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.

Description

RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 14 / 110,873, filed Jan. 30, 2014 (now allowed), which is a national stage application, filed under 35 U.S.C. §371, of International Application No. PCT / US2012 / 033662, filed Apr. 13, 2012, which claims priority to, and the benefit of, U.S. provisional application No. 61 / 474,825, filed Apr. 13, 2011, and 61 / 505,676 filed Jul. 8, 2011, the entire contents of each of which are incorporated herein by reference in their entireties.INCORPORATION-BY-REFERENCE OF SEQUENCE LISTING[0002]The contents of the text file named “EPIZ-008C01US-ST25.txt,” which was created on May 23, 2016 and is 2 KB in size, are hereby incorporated by reference in their entireties.BACKGROUND OF THE INVENTION[0003]In eukaryotic cells DNA is packaged with histones to form chromatin. Changes in the ordered structure of chromatin can lead to alterations in transcription of associated genes. Control of changes in chromatin structure (...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07D213/64C07D405/12C07D491/113C07D491/048C07D405/14C07D409/12C07D491/08C07D401/12C07D401/14
CPCC07D213/64C07D401/12C07D405/12C07D491/113C07D401/14C07D405/14C07D409/12C07D491/08C07D491/048C07D407/12C07D413/12C07D413/14C07D491/10A61P35/00A61K31/4427
Inventor KUNTZ, KEVIN W.CHESWORTH, RICHARDDUNCAN, KENNETH W.KEILHACK, HEIKEWARHOLIC, NATALIEKLAUS, CHRISTINEKNUTSON, SARAH K.WIGLE, TIMOTHY J. N.SEKI, MASASHI
Owner EPIZYME
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com